Summary:
Evanston Premier Healthcare Research is conducting a 26-week randomized, double-blind, active controlled study comparing the safety of fluticasone/formoterol fumarate mdi fixed dose combination versus fluticasone mdi monotherapy in adolescents and adults with persistent asthma.
Qualified Participants Must:
• Be 18 years of age or older
•
Be diagnosed with persistent Asthma for at least a year
•
Be on at least one Asthma medication for at least 4 weeks
•
Have had Asthma exacerbation once in the past year
Qualified Participants May Receive:
Trial medications and exams at no cost, and compensation for time and travel.